• SENSEX 81,451.01
    -182.01 (--0.22%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Suzlon Energy
    74.30 86.04(%)
  • Reliance Power
    60.50 60.50(%)
  • Swiggy
    338.00 617.00(%)
  • Mazagon Dock
    3,450.00 1,200.00(%)
  • Eternal Ltd
    243.00 304.50(%)
  • MMTC
    88.20 131.88(%)
  • Garden Reach Sh.
    2,926.85 1,148.10(%)
  • Waaree Energies
    2,956.60 1,808.65(%)
  • Indian Energy Ex
    203.20 244.35(%)
  • Bharat Dynamics
    2,096.00 2,096.00(%)
  • Engineers India
    239.00 304.00(%)
  • NBCC
    126.41 139.83(%)
  • IFCI
    66.71 35.67(%)
  • Muthoot Finance
    2,241.75 2,444.65(%)
  • HDFC Bank
    1,948.60 1,977.95(%)
  • LMW
    16,640.85 13,456.85(%)
  • Hind.Aeronautics
    4,962.00 3,045.95(%)
  • Pidilite Inds.
    3,127.25 3,414.40(%)
  • Infosys
    1,555.10 1,307.10(%)
  • Ola Electric
    48.07 45.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Aarti Pharmalabs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 75909.0
  • ISIN : INE0LRU01027
911.00 7 (0.78%)
  • As on 31 May 2025 (EOD)

  • Today’s Low

    882.95

  • Today’s High

    917.00

  • Open

    903.95

  • Perv Close

    903.95

  • 52W Low

    497.05

  • 52W High

    917.00

Key Indicators

  • P/E(TTM)

    32.07

  • Mar.Cap (₹Cr.)

    8,256.81

  • Div & Yield %

    0.55

  • Book Value(₹)

    203.44

  • Debt-Equity Ratio

    0.78

  • AGM Date

    30-May-2025

  • EPS

    28.39

  • P/E Ratio

    32.07

Financials Ratios

  • Debt-Equity Ratio

    0.15

  • Mar.Cap (₹Cr.)

    8,256.81

  • RONW (%)

    13.08

  • ROCE (%)

    16.60

Score Board

  • Equity (₹ in Cr.)

    45.32

  • BV (₹)

    203.40

  • Sales( ₹ in Cr.)

    1,771.35

  • NP (in Cr.)

    257.35

  • NP Var(%)

    28.0

  • Div%

    100.0

  • CPS (₹)

    37.10

  • EPS (₹)

    28.40

  • Traded Value (₹ in Lakhs)

    8,250.92

  • 52 Week High

    917.00

  • 52 Week Low

    497.05

  • Price BSE

    910.0

  • Price NSE

    911.00

  • Market Capital( in Cr.)

    8,250.92

  • P/C Ratio

    24.50

  • P/E Ratio

    32.00

  • Price Vs.BV

    28.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 1,502.13 1,511.25 941.02 0.00 0.00 -
Excise Duty 0.00 0.00 0.00 0.00 0.00 -
Net Sales 1,502.13 1,511.25 941.02 0.00 0.00 -
Other Income 11.01 1.28 2.51 0.00 0.00 -
Stock Adjustments 23.36 91.22 32.54 0.00 0.00 -
Total Income 1,536.50 1,603.75 976.07 0.00 0.00 -
EXPENDITURE :            
Raw Materials 775.33 909.15 484.20 0.00 0.00 -
Power and Fuel Cost 82.92 74.22 43.43 0.00 0.00 -
Employee Cost 120.15 113.92 79.98 0.00 0.00 -
Other Manufacturing Expenses 100.94 91.11 164.69 0.00 0.00 -
Selling and Administration Expenses 76.34 82.93 21.46 0.00 0.02 -
Miscellaneous Expenses 23.65 22.80 0.01 0.00 0.00 -
Employee Benefit Expenses 120.15 113.92 79.98 0.00 0.00 -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 -
Total Expenses 1,179.33 1,294.14 793.78 0.00 0.02 -
Operating Profit 357.16 309.62 182.30 0.00 -0.02 -
Interest 16.63 20.49 11.34 0.00 0.00 -
Gross Profit 340.53 289.13 170.96 0.00 -0.02 -
Depreciation 66.01 55.77 37.23 0.00 0.00 -
Profit Before Tax 274.52 233.36 133.73 0.00 -0.02 -
Current Tax 46.06 52.13 22.50 0.00 0.00 -
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 -
Deferred Tax 27.82 9.50 4.50 0.00 0.00 -
Reported Net Profit 200.65 171.73 106.73 0.00 -0.02 -
Extraordinary Items 0.00 0.00 0.03 0.00 0.00 -
Adjusted Net Profit 200.65 171.73 106.70 0.00 -0.02 -
Adjustment below Net Profit 0.00 0.00 599.24 0.00 0.00 -
P & L Balance brought forward 859.55 705.95 -0.02 -0.02 0.00 -
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 -
Appropriations 18.13 18.13 0.00 0.00 0.00 -
P & L Balance carried down 1,042.07 859.55 705.95 -0.02 -0.02 -
Dividend 18.13 18.13 0.00 0.00 0.00 -
Preference Dividend 0.00 0.00 0.00 0.00 0.00 -
Equity Dividend (%) 60.00 40.00 0.00 0.00 0.00 -
Dividend Per Share(Rs) 3.00 2.00 0.00 0.00 0.00 -
Earnings Per Share-Unit Curr 22.14 18.95 4,269.05 -0.18 -0.75 -
Earnings Per Share(Adj)-Unit Curr 22.14 18.95 - - - -
Book Value 178.92 158.74 49,558.52 9.07 9.25 -
Book Value(Adj)-Unit Curr 178.92 158.74 - - - -

Shareholding Pattern

  • Promoter Group

    44.29%

  • Public Share Holding

    55.71%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 155,737 155,737.00 155,737 155,737
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 155,737 0.17 155,737 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 5,927,275 6.54 5,927,275 8
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 25,532,828 28.17 25,532,828 30
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 8,525,360 9.41 8,525,360 9
Others 0 0.00 0 0
Sub Total 39,985,463 44.12 39,985,463 47
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 8,864 0.01 8,864 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1 0.00 1 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 6,669,465 7.36 6,669,465 109
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 5,515,515 6.09 5,515,515 2
Mutual Funds / UTI 709,353 0.78 709,353 7
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 603,436 0.67 603,436 9
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 13,506,634 14.90 13,506,634 129
2] Non Institution
Bodies Corporate 2,521,842 2.78 2,521,842 1,066
Clearing Members 1,055 0.00 1,055 7
Directors of their Relatives 15,103 0.02 15,103 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,465,444 1.62 1,465,444 4,678
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 976,184 1.08 976,184 2,749
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 10,557,195 11.65 10,557,195 69
Individuals holding nominal share capital up to Rs. 1 lakh 20,351,154 22.45 20,351,154 187,435
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 300 0.00 300 3
Others 313,952 0.35 313,952 3
Sub Total 36,986,790 40.81 36,986,790 196,137
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 90,634,624 100.00 90,634,624 196,314

Company Background

Aarti Pharmalabs LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Aarti Pharmalabs Ltd
  • BSE Code : 75909.0
  • ISIN : INE0LRU01027

  • Incorporation Year

    2019

  • Registered Office

    Plot No 22/C/1 & 22/C/2
    1st Phase GIDC Vapi, Valsad,
    Gujarat-396195

  • Telephone

    91-22-6797 6666

  • FAX

    91-22-2565 3234

  • Chairman

    C V Gogri

  • Managing Director

    Narendra Jagannath Salvi

  • Company Secretary

    Jeevan Mondkar

  • Auditor

    Gokhale & Sathe

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Aarti Pharmalabs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Aarti Pharma 910.35 1,513.14 1,502.13 32.07 16.40
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92